Antecedent Administration of Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID‐19 Syndrome

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) utilizes the angiotensin‐converting enzyme‐2 (ACE‐2) receptor to enter human cells. Angiotensin‐converting enzyme inhibitors (ACEI) and angiotensin II receptor antagonists (ARB) are associated with ACE‐2 upregulation. We hypoth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Am Heart Assoc
Hauptverfasser: Palazzuoli, Alberto, Mancone, Massimo, De Ferrari, Gaetano M., Forleo, Giovanni, Secco, Gioel G., Ruocco, Gaetano M., D'Ascenzo, Fabrizio, Monticone, Silvia, Paggi, Anita, Vicenzi, Marco, Palazzo, Anna G., Landolina, Maurizio, Taravelli, Erika, Tavazzi, Guido, Blasi, Francesco, Infusino, Fabio, Fedele, Francesco, De Rosa, Francesco G., Emmett, Michael, Schussler, Jeffrey M., Tecson, Kristen M., McCullough, Peter A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7763715/
https://ncbi.nlm.nih.gov/pubmed/33023356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.017364
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge